We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$23.7B
AUM Growth
+$1.26B
Cap. Flow
+$2.43B
Cap. Flow %
10.25%
Top 10 Hldgs %
31.04%
Holding
1,328
New
56
Increased
716
Reduced
259
Closed
49

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$229M
2
MSFT icon
Microsoft
MSFT
+$208M
3
NVDA icon
NVIDIA
NVDA
+$198M
4
AMZN icon
Amazon
AMZN
+$197M
5
NOW icon
ServiceNow
NOW
+$193M

Top Sells

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$173M
2
SPG icon
Simon Property Group
SPG
+$154M
3
WELL icon
Welltower
WELL
+$114M
4
AMT icon
American Tower
AMT
+$96.9M
5
ELS icon
Equity Lifestyle Properties
ELS
+$88M

Sector Composition

Rank Sector Weight
1 Real Estate 35.46%
2 Technology 23.73%
3 Communication Services 9.02%
4 Consumer Discretionary 6.33%
5 Financials 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XENE icon
1101
Xenon Pharmaceuticals
XENE
$6.1B
$8K ﹤0.01%
252
– –
ARQT icon
1102
Arcutis Biotherapeutics
ARQT
$3.48B
$7K ﹤0.01%
439
– –
KYMR icon
1103
Kymera Therapeutics
KYMR
$8.66B
$7K ﹤0.01%
245
– –
LGND icon
1104
Ligand Pharmaceuticals
LGND
$5.77B
$7K ﹤0.01%
63
– –
MIRM icon
1105
Mirum Pharmaceuticals
MIRM
$6.56B
$7K ﹤0.01%
148
-40
-21% -$1.89K
OPI
1106
DELISTED
Office Properties Income Trust
OPI
$7K ﹤0.01%
14,296
– –
SUPN icon
1107
Supernus Pharmaceuticals
SUPN
$2.7B
$7K ﹤0.01%
209
– –
TARS icon
1108
Tarsus Pharmaceuticals
TARS
$2.55B
$7K ﹤0.01%
137
+30
+28% +$1.48K
VCEL icon
1109
Vericel Corp
VCEL
$2.38B
$7K ﹤0.01%
163
– –
XLK icon
1110
State Street Technology Select Sector SPDR ETF
XLK
$109B
$7K ﹤0.01%
70
– –
AGIO icon
1111
Agios Pharmaceuticals
AGIO
$2.08B
$6K ﹤0.01%
204
– –
BEAM icon
1112
Beam Therapeutics
BEAM
$2.68B
$6K ﹤0.01%
283
– –
DNLI icon
1113
Denali Therapeutics
DNLI
$3.79B
$6K ﹤0.01%
475
– –
HRMY icon
1114
Harmony Biosciences
HRMY
$2.08B
$6K ﹤0.01%
189
– –
IRON icon
1115
Disc Medicine
IRON
$2.81B
$6K ﹤0.01%
113
– –
NVCR icon
1116
NovoCure
NVCR
$1.76B
$6K ﹤0.01%
357
– –
AMPH icon
1117
Amphastar Pharmaceuticals
AMPH
$907M
$5K ﹤0.01%
185
– –
ANIP icon
1118
ANI Pharmaceuticals
ANIP
$1.86B
$5K ﹤0.01%
70
– –
APGE icon
1119
Apogee Therapeutics
APGE
$10.1B
$5K ﹤0.01%
131
-40
-23% -$1.55K
ARWR icon
1120
Arrowhead Research
ARWR
$12.1B
$5K ﹤0.01%
426
– –
BCRX icon
1121
BioCryst Pharmaceuticals
BCRX
$2.42B
$5K ﹤0.01%
692
– –
CGON icon
1122
CG Oncology
CGON
$6.1B
$5K ﹤0.01%
223
– –
DBC icon
1123
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$5K ﹤0.01%
200
– –
DVAX
1124
DELISTED
Dynavax Technologies
DVAX
$5K ﹤0.01%
409
-120
-23% -$1.59K
JANX icon
1125
Janux Therapeutics
JANX
$912M
$5K ﹤0.01%
187
– –
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2025 Portfolio in Review

As of Q1 2025, Daiwa Securities Group held 1,328 positions worth $23.7B, up 5.6% from $22.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Daiwa Securities Group deployed $2.43B of net new capital in Q1 2025, opening 56 new positions and adding to 716 existing holdings. Its largest new stake was Autoliv: 89,727 shares worth $7.94M.

By sector, the portfolio is most concentrated in Real Estate at 35% of assets, down from 38% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was VICI Properties, an estimated $173M trimmed.

  • Daiwa Securities Group's largest Q1 2025 buy was Autoliv: 89,727 shares worth $7.94M.
  • Daiwa Securities Group added most to Apple in Q1 2025, an estimated $229M increase.
  • Daiwa Securities Group's biggest Q1 2025 reduction was VICI Properties, cutting an estimated $173M.
  • Daiwa Securities Group fully exited Global X SuperDividend REIT ETF in Q1 2025, selling an estimated $20.8M.
  • Daiwa Securities Group's ten largest holdings make up 31% of its $23.7B portfolio in Q1 2025.
  • Daiwa Securities Group opened 56 new positions and closed 49 in Q1 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $23.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2025, filed 13 May 2025.